Explore more publications!

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on February 19, 2026

Arionkoder Joins ViVE 2026 to Address the Challenge of Trustworthy AI in Healthcare
Introducing the 2026 North America eSIM Plan: 23GB to Celebrate the 23rd World Cup
TTA Named to Training Industry’s 2026 Leadership Training Watch List for Ninth Consecutive Year
IVC Expands Custom Engineering Capabilities with Corrosion-Resistant Camera Solution
SynDevRx Publishes Data On Evexomostat Establishing New Metabo-Oncology Therapeutic Modality
ScribeEMR to Exhibit ScribeRyte AI Clinical Documentation Solutions at HIMSS (Booth #645)
Spice Labs Introduces the Complex Spice Podcast
New Wave Recovery Center Launches Specialized Treatment Tracks for Kratom and Stimulant Addiction in Massachusetts
METALCON 2026 Makes Its Orlando Debut at the Orange County Convention Center
Leaders Excellence at Harvard Square Launches AI Leadership Elective in Mini-MBA
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
CarGurus Announces Fourth Quarter and Full-Year 2025 Results
Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2025
Candel Therapeutics Announces Proposed $100 Million Public Offering
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Akamai Reports Fourth Quarter 2025 and Full-Year 2025 Financial Results
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
ALIT Down 35%: Alight, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors to Contact the Firm to Recover Losses

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions